While previous studies highlighted roles for HIF-1α and VEGF in melanoma angiogenesis [15, 16], there are no previous data on the relative importance of angiogenesis or response to anti-angiogenic therapy in BRAFWT vs. BRAFMut melanoma models or primary patient tumors. The gene discussed is HIF1A; the disease is melanoma.